Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25)
Titel:
Neutrophil-to-Eosinophil Ratio Predicts the Efficacy of Avelumab in Patients With Advanced Urothelial Carcinoma Enrolled in the MALVA Study (Meet-URO 25)
Auteur:
Gambale, Elisabetta Maruzzo, Marco Messina, Carlo De Gennaro Aquino, Irene Vascotto, Ismaela Anna Rossi, Virginia Bimbatti, Davide Cavasin, Nicolò Messina, Marco Mennitto, Alessia Rebuzzi, Sara Elena Nasso, Cecilia Mercinelli, Chiara Maiorano, Brigida Anna Fanelli, Martina Sorarù, Mariella Scolari, Federico Mela, Marinella Micol Galli, Luca Salfi, Alessia Rizzo, Mimma Puglisi, Silvia Orlando, Valentina Fornarini, Giuseppe Rametta, Alessandro Giannatempo, Patrizia Cerbone, Linda Doni, Laura Roviello, Giandomenico Pillozzi, Serena Antonuzzo, Lorenzo